This study was designed to determine whether neuroleptic drugs have calcium channel blocking activity in isolated rings of rabbit thoracic aorta. The results confirm previous findings that pimozide and penfluridol are calcium channel blockers. However, the data do not support the conclusion that these agents are selective for the voltage-sensitive calcium channel. The results also show that both haloperidol and chlorpromazine (which represent different classes of neuroleptic drugs) are also calcium channel blockers in vascular smooth muscle.
It has been suggested (1) that neuroleptic drugs of the diphenylbutylpiperidine class (pimozide and penfluridol), which differ from other neuroleptics (phenothiazines and butyrophenones) in their ability to relieve both negative and positive symptoms of schizophrenia, owe their activity to an ability to antagonize voltage-dependent calcium channel activity in the brain. These neuroleptic drugs selectively inhibit the binding of [3H] nitrendipine to a rat cerebral cortical membrane fraction and also competitively antagonize potassium-induced calcium-dependent contractions in rat vas deferens. Inhibition of calcium-dependent contractile activity in smooth muscle can be attributed to effects on calcium-dependent mechanisms within the cell that are independent of calcium influx across the cell membrane (2) .
To test directly the hypothesis that drugs of the diphenylbutylpiperidine class are calcium influx blockers, we measured their effects on the rates of calcium influx in isolated rings of rabbit thoracic aorta (i) under control conditions, (it) during activation of a receptor-operated calcium channel (ROC) by norepinephrine (NE) , and (iii) during activation of the potential-dependent calcium channel (PDC) by potassium chloride. Effects on isometric contractile force also were determined. Pimozide and penfluridol (diphenylbutylpiperidines) were compared to chlorpromazine (a phenothiazine), haloperidol (a butyrophenone), prazosin (an a, adrenergic ROC blocker), nifedipine (a PDC blocker), and lanthanum chloride (a nonselective calcium channel blocker).
METHODS
All studies were conducted on tissue taken from male New Zealand White rabbits (2.2-2.4 kg), using previously described methods (3, 4 Isometric Tension. To record isometric tension, we placed each 3 mm long vascular ring across two stainless steel wires in a chamber containing 20 ml of fresh oxygenated PS solution at 370C. The lower wire was secured firmly to an oxygenator, while the upper wire was connected to a tension transducer. Each vascular ring was adjusted to maintain resting (base-line) tension of 1 g during a 60-min equilibration period. After equilibration, tests were begun. Any change in tension from baseline constituted active generated isometric tension. This active tension was recorded over time and was expressed either as mg of tension above the base line generated per mg of wet tissue for concentration-response tests or as a % of the maximum tension generated in the same ring during a previous stimulation by the agonist. 
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Stimulation of the rings by KCl could be attributed entirely to stimulation of the PDC. Nifedipine significantly inhibited the time-tension response (Fig. 2B) , and the calcium-influx response (Table 1) to KCl stimulation but had no effect on the magnitude of the tension response to NE ( Fig. 2A) and only slightly inhibited the calcium-influx response to NE (Table 1) . Nifedipine caused a slight delay in the time-toRmax during NE stimulation ( Fig. 2A Inset) and significantly decreased the time-to-Rmax during KCI stimulation (Fig. 2B Inset; see also Fig. 4B ).
Lanthanum chloride significantly reduced the isometrictension responses to both NE (Fig. 3A) and KCl (Fig. 3B ) over time. Similar parallel inhibitory effects were observed for the agonist-induced calcium-influx responses (Table 1) . Lanthanum chloride reduced time-to-Rmax during KCI stimulation (Fig. 3B Inset) . Pimozide (Fig. 4D) (Fig. 4C) , suppressed the contractile response to but had no effect on time-to-Rmax for KCl and inhibited calcium-influx during both NE and Data represent mean rates of NE (10 uM)-or KCI (60 mM)-stimulated influx above basal influx through the leak channel. For each entry, n = 6. *Lanthanum chloride was tested at 0.1, 1.0, and 5.0 mM.
KCl stimulation (Table 1) . Haloperidol suppressed contractile force induced by either NE or KCl (Fig. 4F) , increased time-to-Rmax during NE stimulation, decreased time-to-Rmax during KCl stimulation, and inhibited both NE-and KCl-induced calcium uptake (Table 1) .
To determine the concentration of the experimental agent that was required to achieve total inhibition of NE-or KClinduced calcium influx, agonist-induced calcium influx above basal influx was calculated for each concentration of experimental agent from the mean data presented in Table 1 . These results are presented in Table 2 . 
DISCUSSION
The results of this study show that compounds belonging to three classes of neuroleptic drugs are capable of inhibiting calcium influx into vascular smooth muscle cells during stimulation of either the ROC or the PDC. Although these compounds have been previously shown to have inhibitory effects on calcium-dependent smooth muscle activity (1), their direct reduction of calcium influx rate has not been shown previously.
The neuroleptic agents used in this study all have been shown to have anticalmodulin activity with IC50s ranging from 3 to 65 tkM (8) . From Table 2 , it can be seen that the neuroleptic agents also reduced calcium influx rate through both the ROC and the PDC over the concentration range of 0.1 to 10.0 AM.
There was a clear difference among the various neuroleptic agents when the Rmax vs. time-to-Rmax plots for NE stimulation were compared (Fig. 4) . It should be noted that little or no membrane depolarization occurs in rabbit thoracic aorta during NE stimulation (9) . These results suggest that the inhibitory effects of chlorpromazine and haloperidol are much like those of prazosin and may involve a simple a, blocking effect. All agents suppressed the KCl-induced Rmax in a fashion similar to that seen with either lanthanum chloride or nifedipine.
Calmodulin antagonists can interfere directly with force development by affecting myosin phosphorylation, independent of sarcolemmal calcium influx (10) (11) (12) . Myosin phosphorylation in smooth muscle correlates with the rate of force development (i.e., time-to-Rmax) but not necessarily with the maintenance of force (i.e., Rmax). In view of these findings, calmodulin antagonists would be expected to have a greater effect on time-to-Rmax than on Rmax. This, however, was not the case (Fig. 4) ; only nifedipine (which is not considered to be an important calmodulin antagonist) significantly increased time-to-Rmax without inhibiting Rmax itself during NE stimulation.
To provide a clearer picture of potential correlations within the data sets, Figs. 5 and 6 were constructed. Fig. 5 correlates the rate of calcium influx with time-to-Rmax during treatment with the various experimental agents. Fig. 6 Thus, based on the correlations presented (Figs. 4-6 ), it appears that the differences between these neuroleptic drugs involve their respective effects on the parameters of time-toRmax, especially during norepinephrine stimulation. The data suggest that the diphenylbutylpiperidines are capable of inhibiting the ROC without affecting the intracellular calcium release mechanism that is normally associated with a, adrenergic receptor activation. Chlorpromazine and haloperidol, on the other hand, appear to inhibit both the NE-sensitive ROC and the intracellular calcium release mechanism associated with a,-receptor activation. This latter situation is suggestive of simple a1-receptor blockade and is supported by the findings of Gould et al. (1) .
Perhaps the most interesting aspect of our studies is that calmodulin inhibitors were found to reduce the rate of calcium influx through at least two types of calcium channels in the vascular smooth muscle cell. It has been suggested that calcium channels may contain a calmodulin-like calcium receptor (13) . Drugs that bind to calmodulin have been shown to increase the affinity of that molecule to calcium (14) . Johnson (13) has suggested, therefore, that calcium antagonists may bind to the calcium-binding protein, thereby causing an increase in the affinity of that protein for calcium and thus facilitating the closure of the calcium channel. This could explain the effects of the neuroleptic drugs on calcium influx observed in the present study.
In conclusion, we have shown that three different classes of neuroleptic agents are capable of reducing the rate of calcium influx through both the NE-sensitive ROC and the PDC in vascular smooth muscle of rabbit aorta. These findings support the hypothesis that a calcium-binding protein may be incorporated in the calcium channel in this tissue.
